This clinical trial is focused on studying certain types of cancer, specifically those affecting the pancreas, esophagus, liver, and ovaries. These cancers are advanced, have come back, or are getting worse after initial treatments. The study is testing a new treatment called WT1/IL15/IL15Ra mRNA DC, which is a type of vaccine made from a patient’s own cells. This vaccine is designed to help the immune system recognize and fight cancer cells more effectively.
The purpose of the study is to see if this new vaccine can be safely made and given to patients with these types of cancer. The vaccine is given as an injection just under the skin. Patients will receive the vaccine and be monitored to see how their bodies respond to the treatment. The study will also look at how the vaccine affects the patients’ quality of life and how their cancer responds to the treatment over time.
Throughout the study, researchers will keep track of any side effects and how well the vaccine is working. The goal is to find out if this new approach can be a safe and effective option for people with these challenging types of cancer. The study is expected to continue until 2026, with the hope of providing new insights into cancer treatment.



Belgium